Use as initial testing panel to aid in the diagnosis of and distinguishing among skin and mucous membrane disorders that present with blistering, erosions, eczema, pruritus, and/or urticaria, including pemphigoid, pemphigoid variants, epidermolysis bullosa acquisita (EBA), linear IgA bullous dermatosis, linear IgA disease variants, bullous lupus erythematosus and IgG-pemphigus subtypes. Use for assessment of suspected epithelial antibody-associated immunobullous diseases that may be nonspecific, may not be clinically distinguishable, may present with overlapping epithelial antibody expression, and/or may be indicated by concurrent Cutaneous Direct Immunofluorescence, Biopsy (0092572).
Immunobullous Disease Panel, Epithelial, (3001409) components include Epithelial Basement Membrane Zone IgG Antibodies (0092056), Epithelial Basement Membrane Zone IgA Antibodies (0092057), Bullous Pemphigoid (180&230) IgG Antibodies (0092566), Collagen Type VII Antibody IgG (2010905), IgG Epithelial Cell Surface Antibodies (0090266), IgG Desmoglein 1 & Desmoglein 3 (0090649), and IgA (Cell Surface) Pemphigus (0092106).
Indirect Fluorescent Antibody/Enzyme-Linked Immunosorbent Assay
Plain Red or Serum Separator Tube (SST).
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Hemolyzed or Lipemic specimens. Plasma
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely
Refer to report
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
88346; 88350 x5; 83516 x5
|Component Test Code*||Component Chart Name||LOINC|
|3001665||Immunobullous Disease Panel|
|3001666||EER Immunobullous Disease Panel|